Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jouni Vesa

    TitleSpecialist
    SchoolUniversity of California, San Diego
    DepartmentPediatrics
    Address9500 Gilman Drive #0984
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Vesa J, Chaillon A, Wagner GA, Anderson CM, Richman DD, Smith DM, Little SJ. Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles. AIDS. 2017 May 15; 31(8):1149-1158. PMID: 28244954.
        View in: PubMed
      2. Minye HM, Fabritius AL, Vesa J, Peltonen L. Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin. Data Brief. 2016 Sep; 8:741-9. PMID: 27508227.
        View in: PubMed
      3. Nalbandian A, Llewellyn KJ, Gomez A, Walker N, Su H, Dunnigan A, Chwa M, Vesa J, Kenney MC, Kimonis VE. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics. Mitochondrion. 2015 May; 22:1-8. PMID: 25724235.
        View in: PubMed
      4. Nalbandian A, Ghimbovschi S, Wang Z, Knoblach S, Llewellyn KJ, Vesa J, Hoffman EP, Kimonis VE. Global Gene Expression Profiling in R155H Knock-In Murine Model of VCP Disease. Clin Transl Sci. 2015 Feb; 8(1):8-16. PMID: 25388089.
        View in: PubMed
      5. Fabritius AL, Vesa J, Minye HM, Nakano I, Kornblum H, Peltonen L. Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain. Exp Mol Pathol. 2014 Dec; 97(3):484-91. PMID: 25303899.
        View in: PubMed
      6. Nalbandian A, Llewellyn KJ, Badadani M, Yin HZ, Nguyen C, Katheria V, Watts G, Mukherjee J, Vesa J, Caiozzo V, Mozaffar T, Weiss JH, Kimonis VE. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse. Muscle Nerve. 2013 Feb; 47(2):260-70. PMID: 23169451.
        View in: PubMed
      7. Nalbandian A, Ghimbovschi S, Radom-Aizik S, Dec E, Vesa J, Martin B, Knoblach S, Smith C, Hoffman E, Kimonis VE. Global gene profiling of VCP-associated inclusion body myopathy. Clin Transl Sci. 2012 Jun; 5(3):226-34. PMID: 22686199.
        View in: PubMed
      8. Uusi-Rauva K, Kyttälä A, van der Kant R, Vesa J, Tanhuanpää K, Neefjes J, Olkkonen VM, Jalanko A. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments. Cell Mol Life Sci. 2012 Jun; 69(12):2075-89. PMID: 22261744.
        View in: PubMed
      9. Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J Mol Neurosci. 2011 Nov; 45(3):522-31. PMID: 21892620.
        View in: PubMed
      10. Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, Caiozzo V, Warman M, Kimonis VE. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One. 2010; 5(10). PMID: 20957154.
        View in: PubMed
      11. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010 Feb; 6(2):217-27. PMID: 20104022.
        View in: PubMed
      12. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord. 2009 Nov; 19(11):766-72. PMID: 19828315.
        View in: PubMed
      13. Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH, Potluri P, Procaccio V, Acab A, Weiss JH, Wallace DC, Kimonis VE. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci Lett. 2011 Jan 7; 487(2):129-33. PMID: 19563863.
        View in: PubMed
      14. Kimonis VE, Fulchiero E, Vesa J, Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta. 2008 Dec; 1782(12):744-8. PMID: 18845250.
        View in: PubMed
      15. Mee L, Honkala H, Kopra O, Vesa J, Finnilä S, Visapää I, Sang TK, Jackson GR, Salonen R, Kestilä M, Peltonen L. Hydrolethalus syndrome is caused by a missense mutation in a novel gene HYLS1. Hum Mol Genet. 2005 Jun 1; 14(11):1475-88. PMID: 15843405.
        View in: PubMed
      16. Vesa J, Brown Y, Greenfield D, Korenberg JR. Molecular and cellular characterization of the Down syndrome critical region protein 2. Biochem Biophys Res Commun. 2005 Mar 4; 328(1):235-42. PMID: 15670775.
        View in: PubMed
      17. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL, Salonen T, Rapola J, Gentile M, Kopra O, Peltonen L. Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiol Dis. 2005 Feb; 18(1):226-41. PMID: 15649713.
        View in: PubMed
      18. Kopra O, Vesa J, von Schantz C, Manninen T, Minye H, Fabritius AL, Rapola J, van Diggelen OP, Saarela J, Jalanko A, Peltonen L. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum Mol Genet. 2004 Dec 1; 13(23):2893-906. PMID: 15459177.
        View in: PubMed
      19. Kyttälä A, Ihrke G, Vesa J, Schell MJ, Luzio JP. Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Mol Biol Cell. 2004 Mar; 15(3):1313-23. PMID: 14699076.
        View in: PubMed
      20. Kaunisto MA, Harno H, Kallela M, Somer H, Sallinen R, Hämäläinen E, Miettinen PJ, Vesa J, Orpana A, Palotie A, Färkkilä M, Wessman M. Novel splice site CACNA1A mutation causing episodic ataxia type 2. Neurogenetics. 2004 Feb; 5(1):69-73. PMID: 14530926.
        View in: PubMed
      21. Visapää I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet. 2002 Oct; 71(4):863-76. PMID: 12215968.
        View in: PubMed
      22. Vesa J, Peltonen L. Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins. Curr Mol Med. 2002 Aug; 2(5):439-44. PMID: 12125809.
        View in: PubMed
      23. Vesa J, Chin MH, Oelgeschläger K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol Biol Cell. 2002 Jul; 13(7):2410-20. PMID: 12134079.
        View in: PubMed
      24. Isosomppi J, Vesa J, Jalanko A, Peltonen L. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet. 2002 Apr 15; 11(8):885-91. PMID: 11971870.
        View in: PubMed
      25. Salonen T, Heinonen-Kopra O, Vesa J, Jalanko A. Neuronal trafficking of palmitoyl protein thioesterase provides an excellent model to study the effects of different mutations which cause infantile neuronal ceroid lipofuscinocis. Mol Cell Neurosci. 2001 Aug; 18(2):131-40. PMID: 11520175.
        View in: PubMed
      26. Peltonen L, Savukoski M, Vesa J. Genetics of the neuronal ceroid lipofuscinoses. Curr Opin Genet Dev. 2000 Jun; 10(3):299-305. PMID: 10826995.
        View in: PubMed
      27. Isosomppi J, Heinonen O, Hiltunen JO, Greene ND, Vesa J, Uusitalo A, Mitchison HM, Saarma M, Jalanko A, Peltonen L. Developmental expression of palmitoyl protein thioesterase in normal mice. Brain Res Dev Brain Res. 1999 Dec 10; 118(1-2):1-11. PMID: 10611498.
        View in: PubMed
      28. Hellsten E, Vesa J, Jalanko A, Peltonen L. From locus to cellular disturbances: positional cloning of the infantile neuronal ceroid lipofuscinosis gene. Neuropediatrics. 1997 Feb; 28(1):9-11. PMID: 9151310.
        View in: PubMed
      29. Syvänen AC, Järvelä I, Paunio T, Vesa J. DNA diagnosis and identification of carriers of infantile and juvenile neuronal ceroid lipofuscinoses. Neuropediatrics. 1997 Feb; 28(1):63-6. PMID: 9151326.
        View in: PubMed
      30. Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J. 1996 Oct 1; 15(19):5240-5. PMID: 8895569.
        View in: PubMed
      31. Järvelä I, Hellsten E, Vesa J, Palotie L. [The molecular etiology of neuronal ceroid lipofuscinosis]. Duodecim. 1996; 112(13):1139-41. PMID: 10596080.
        View in: PubMed
      32. Mäkelä TP, Hellsten E, Vesa J, Hirvonen H, Palotie A, Peltonen L, Alitalo K. The rearranged L-myc fusion gene (RLF) encodes a Zn-15 related zinc finger protein. Oncogene. 1995 Dec 21; 11(12):2699-704. PMID: 8545128.
        View in: PubMed
      33. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 1995 Aug 17; 376(6541):584-7. PMID: 7637805.
        View in: PubMed
      34. Goebel HH, Vesa J, Reitter B, Goecke TO, Schneider-Rätzke B, Merz E. Prenatal diagnosis of infantile neuronal ceroid-lipofuscinosis: a combined electron microscopic and molecular genetic approach. Brain Dev. 1995 Mar-Apr; 17(2):83-8. PMID: 7625554.
        View in: PubMed
      35. Almqvist E, Spence N, Nichol K, Andrew SE, Vesa J, Peltonen L, Anvret M, Goto J, Kanazawa I, Goldberg YP. Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet. 1995 Feb; 4(2):207-14. PMID: 7757069.
        View in: PubMed
      36. Hellsten E, Vesa J, Heiskanen M, Mäkelä TP, Järvelä I, Cowell JK, Mead S, Alitalo K, Palotie A, Peltonen L. Identification of YAC clones for human chromosome 1p32 and physical mapping of the infantile neuronal ceroid lipofuscinosis (INCL) locus. Genomics. 1995 Jan 20; 25(2):404-12. PMID: 7789974.
        View in: PubMed
      37. Vesa J, Hellsten E, Barnoski BL, Emanuel BS, Billheimer JT, Mead S, Cowell JK, Strauss JF, Peltonen L. Assignment of sterol carrier protein X/sterol carrier protein 2 to 1p32 and its exclusion as the causative gene for infantile neuronal ceroid lipofuscinosis. Hum Mol Genet. 1994 Feb; 3(2):341-6. PMID: 8004106.
        View in: PubMed
      38. Williams R, Vesa J, Järvelä I, McKay T, Mitchison H, Hellsten E, Thompson A, Callen D, Sutherland G, Luna-Battadano D. Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes. Am J Hum Genet. 1993 Oct; 53(4):931-5. PMID: 8213822.
        View in: PubMed
      39. Hellsten E, Vesa J, Speer MC, Mäkelä TP, Järvelä I, Alitalo K, Ott J, Peltonen L. Refined assignment of the infantile neuronal ceroid lipofuscinosis (INCL, CLN1) locus at 1p32: incorporation of linkage disequilibrium in multipoint analysis. Genomics. 1993 Jun; 16(3):720-5. PMID: 8325646.
        View in: PubMed
      40. Hellsten E, Vesa J, Järvelä I, Mäkelä TP, Santavuori P, Peltonen L. Refined assignment of the infantile neuronal ceroid-lipofuscinosis (INCL) locus at 1p32 and the current status of prenatal and carrier diagnostics. J Inherit Metab Dis. 1993; 16(2):335-8. PMID: 8411993.
        View in: PubMed
      41. Vesa J, Hellsten E, Mäkelä TP, Järvelä I, Airaksinen T, Santavuori P, Peltonen L. A single PCR marker in strong allelic association with the infantile form of neuronal ceroid lipofuscinosis facilitates reliable prenatal diagnostics and disease carrier identification. Eur J Hum Genet. 1993; 1(2):125-32. PMID: 7914464.
        View in: PubMed
      42. Järvelä I, Vesa J, Santavuori P, Hellsten E, Peltonen L. Molecular genetics of neuronal ceroid lipofuscinoses. Pediatr Res. 1992 Dec; 32(6):645-8. PMID: 1287553.
        View in: PubMed
      43. Mäkelä TP, Hellsten E, Vesa J, Alitalo K, Peltonen L. An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. Hum Mol Genet. 1992 Jun; 1(3):217. PMID: 1303189.
        View in: PubMed
      44. Järvelä I, Rapola J, Peltonen L, Puhakka L, Vesa J, Ammälä P, Salonen R, Ryynänen M, Haring P, Mustonen A. DNA-based prenatal diagnosis of the infantile form of neuronal ceroid lipofuscinosis (INCL, CLN1). Prenat Diagn. 1991 May; 11(5):323-8. PMID: 1680233.
        View in: PubMed